Fibroblasts from Wharton's Jelly

Umbilical-cord (Wharton's jelly) fibroblasts are young, highly proliferative cells rich in growth factors and extracellular-matrix proteins, applied in aesthetic and regenerative protocols.

How Fibroblasts from Wharton's Jelly are used

The therapeutic value of Fibroblasts from Wharton's Jelly lies less in cells "becoming" new tissue and more in their paracrine signalling — the growth factors and vesicles they release to calm inflammation and recruit the body's own repair. Delivery is matched to the target: intravenous for systemic conditions, or localised where appropriate.

Conditions where Fibroblasts from Wharton's Jelly feature

Quality & safety

• GMP-certified preparation in the European Union
• Characterised, viability-tested cells from a certified bank
• Personalised dosing within a physician-led protocol
• Transparent pricing — €3,000–€8,000 per programme

Educational information. Fibroblasts from Wharton's Jelly protocols for several conditions remain investigational; outcomes vary by patient.